Charles River Announces Local Alliance in Australia
October 14, 2011- Charles River Biopharmaceutical Services (BPS) is pleased to announce a new alliance with JDJ Bioservices, an Australian biotechnology services and consultancy business. This company will be the representative for Charles River BPS in Australia and New Zealand.Charles River BPS delivers client-focused solutions tailored to the specific testing and manufacturing requirements of biologics. The five BPS facilities, located in the U.S., U.K., Ireland, and Germany, are part of a global scientific network supporting clients throughout the biologic development cycle from the establishment and characterization of cell banks through preclinical and clinical studies to marketed product. The BPS sites follow international regulatory guidelines for testing and clinical-scale manufacturing of biologics. Assays offered range from cell characterization and process validation studies to stability and product release testing. Manufacturing services include cell banking and storage, fill and finish, and viral vaccine and antisera production. These testing and manufacturing services help clients accelerate their drug development from concept to product release.
“We are very excited to be associated with JDJ Bioservices,” remarked Dr. Howard Ratcliffe, Global Director of Business Development and Sales, Charles River Biopharmaceutical Services. “JDJ Bioservices has extensive experience in the conduct of R&D in the Australian biotechnology area, as well as an outstanding track record in delivering for clients.”
“We are very happy to be working with Charles River Laboratories, one of the world’s foremost R&D contract research organizations in the biologics area,” stated JDJ Bioservices’ CEO Dr. Julian Chick. “This expands the range of services that JDJ Bioservices can offer to the Australian biotechnology and research community.”
This partnership also provides a single point of contact for Charles River BPS clients in Australia and New Zealand, providing the flexibility of a local supplier, with the support of a large organization.
For more information, please contact us at email@example.com.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
We can now analyze immunohistochemical biomarkers using a confocal microscope by having multiple images taken at relatively high magnification, thus allowing us the ability to construct an image of the brain section in good resolution.
Our newly validated ELISpot and FluoroSpot reader services are some of the most sensitive cellular assays available. With this technology, we now offer an even wider range of services to meet vaccine development needs.
Jun 24–Jun 26
Charles River is once again delighted to be supporting Skin Forum. Our expert scientists will be attending the Annual Meeting and will be happy to meet with you to discuss your dermal product requirements and help you determine how our global capabilities can benefit your development program.
Jun 21–Jun 25
This five-day meeting draws diverse professionals from around the world to share their breakthroughs in the prevention, diagnosis and treatment of diabetes.
Sep 09–Sep 11
This year's "Biotechnology-Derived Therapeutics: Perspectives on Nonclinical Development" Symposium will be held on September 9-11 at the Hilton Carlsbad Oceanfront Resort and Spa in Carlsbad, CA. This Charles River sponsored event unites drug development professionals in an interactive setting to discuss the nonclinical development of biologics, including regulatory issues and innovative approaches to problem-solving.
Jun 28–Jun 28
Charles River offers a wide range of seminars, workshops and training courses for animal technicians, veterinarians, biologists and laboratory technicians who work with laboratory animals. For more information about our course on animal health monitoring, click "view more" below.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.